SCHEMBL2366417

SCHEMBL2366417

O=CN1CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27386849 0.84
SCHEMBL7321 0.82
SCHEMBL11841381 0.82
Hydrochloric Acid SCHEMBL3855161 0.80 CA12 (0.38)
Hydrochloric Acid SCHEMBL5012159 0.80
SCHEMBL13434243 0.80 SMN1; SMN2 (0.39)
SCHEMBL16607618 0.80 SMN1; SMN2 (0.39)
SCHEMBL27693198 0.78 CA12 (0.36)
SCHEMBL25224342 0.76 TSHR (0.43)
SCHEMBL4874102 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176163-B1 NOVEL INDENE DERIVATIVE, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING RETINAL DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT IAC IN NAT UNIV CHUNGNAM (KR) 2019-04-17 EP claimed
US-20170152268-A1 NOVEL INDENE DERIVATIVE, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITION, FOR PREVENTING OR TREATING RETINAL DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT MOTHER'S PHARMACEUTICAL CO., LTD. (KR) 2017-06-01 US claimed
WO-2024101402-A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLIC COMPOUND HAVING SELECTIVE KRAS INHIBITORY EFFECT AGAINST HRAS AND NRAS 中外製薬株式会社 2024-05-16 WO disclosed
US-20240158446-A1 CYCLIC COMPOUND HAVING SELECTIVE INHIBITORY ACTION ON KRAS OVER HRAS AND NRAS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-05-16 US disclosed
WO-2024101386-A1 CYCLIC COMPOUND HAVING SELECTIVE KRAS INHIBITORY EFFECT ON HRAS AND NRAS 中外製薬株式会社 2024-05-16 WO disclosed
WO-2024096023-A1 METHOD FOR REMOVING DIBENZOFULVENE OR DIBENZOFULVENE DERIVATIVE 中外製薬株式会社 2024-05-10 WO disclosed
US-20240148821-A1 PHARMACEUTICAL USE OF CYCLIC PEPTIDE COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-05-09 US disclosed
WO-2024085235-A1 METHOD FOR PRODUCING CYCLIC PEPTIDE CRYSTALS 中外製薬株式会社 2024-04-25 WO disclosed
WO-2024080308-A1 COMPOSITION CONTAINING PEPTIDE, SURFACTANT, AND POLYMER 中外製薬株式会社 2024-04-18 WO disclosed
US-20240124517-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND CONTAINING N-SUBSTITUTED-AMINO ACID RESIDUE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-04-18 US disclosed
WO-2024080333-A1 METHOD FOR PRODUCING N-SUBSTITUTED AMINO ACID RESIDUE-CONTAINING CYCLIC PEPTIDE COMPOUND 中外製薬株式会社 2024-04-18 WO disclosed
CN-100462351-C Amino acids having affinity for the alpha 2 delta protein WARNER LAMBERT CO (US) 2009-02-18 CN disclosed
US-20070244145-A1 Cyclic Amine Compound TAISHO PHARMACEUTICAL CO., LTD. (JP) 2007-10-18 US disclosed
EP-1757605-A1 CYCLIC AMINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2007-02-28 EP disclosed
CN-1817854-A Amino acids with affinity for the alpha-2-delta protein WARNER LAMBERT CO (US) 2006-08-16 CN disclosed
CN-1768051-A Substituted pyrazoles MERCK PATENT GMBH (DE) 2006-05-03 CN disclosed
CN-1674884-A Synergistic combination of an alpha-2-delta ligand and a PDEV inhibitor for use in the treatment of pain PFIZER LTD (US) 2005-09-28 CN disclosed
CN-1653036-A Amino acids having affinity for the alpha 2 delta protein WARNER LAMBERT CO (US) 2005-08-10 CN disclosed
CN-1060161-C N-substituted phenylcarbamic acid derivatives, process for production thereof, agricultural and horticultural fungicides, intermediates of derlvatives and process for production thereof NIHON NOHYAKU CO LTD (JP) 2001-01-03 CN disclosed
CN-1132744-A N-substituted phenylcarbamic acid derivatives, process for production thereof, agricultural and horticultural fungicides, intermediates of derlvatives and process for production thereof NIHON NOHYAKU CO LTD (JP) 1996-10-09 CN disclosed